title: Sapho syndrome with femoral hyperostosis. Two case-reports.
abstract: A characteristic manifestation of SAPHO syndrome is hyperostosis, which most typically affects the sternoclavicular joints. Two cases of SAPHO syndrome with painful hyperostosis of the femur are reported. This misleading localization can lead to delays in the diagnosis and treatment.
authors.affiliation: Department of Rheumatology and Bone Diseases, Edouard Herriot Hospital, Lyon, France.
authors.forename: C
authors.initials: C
authors.lastname: Collange
authors.forename: J F
authors.initials: JF
authors.lastname: Brantus
authors.forename: C
authors.initials: C
authors.lastname: Sidot
authors.forename: P J
authors.initials: PJ
authors.lastname: Meunier
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D005269:Femur / Q000000981:diagnostic imaging / Q000503:physiopathology; D006801:Humans; D015576:Hyperostosis / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D010000:Osteitis / Q000150:complications*; D010146:Pain; D000077268:Pamidronate; D011565:Psoriasis / Q000150:complications*; D011859:Radiography; D011877:Radionuclide Imaging; D012460:Sulfasalazine / Q000627:therapeutic use; D013577:Syndrome; D013585:Synovitis / Q000150:complications*
chemical_list: D018501:Antirheumatic Agents; D004164:Diphosphonates; D012460:Sulfasalazine; D000077268:Pamidronate